Product Program year 2019 Source: CMS Open Payments

Clindacin PAC

Drug Dermatology

NDC 43538-171-69

Open in the dashboard

General payments

$307

18 payments

Research payments

$0

0 payments

Through program year 2019, $307 in general payments and $0 in research payments were reported against Clindacin PAC (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $307 18

Breakdown

Who paid General payments · program year 2019
  1. Medimetriks Pharmaceuticals, Inc. $307 18 payments
Top recipients General payments · program year 2019
  1. David Mai Podiatrist, Foot & Ankle Surgery · Miami Lakes, FL $115 37% · 1 payment
  2. Harold Farber Dermatology · Philadelphia, PA $95 31% · 10 payments
  3. Vaughan Graves Dermatology · Cherry Hill, NJ $25 8% · 1 payment
  4. Shaza Daoud Internal Medicine · Parma, OH $18 6% · 1 payment
  5. Michael Reep Dermatology · Westlake, OH $13 4% · 1 payment

The top 5 of 9 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Dermatology $175 57% · 7 practitioners
  2. Podiatrist, Foot & Ankle Surgery Podiatrist $115 37% · 1 practitioner
  3. Internal Medicine $18 6% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Pennsylvania $120 39% · 2 recipients
  2. Florida $115 37% · 1 recipient
  3. Ohio $68 22% · 5 recipients
  4. Tennessee $4 1% · 1 recipient

Each share is of general payments naming this product in 2019 where a state was reported.

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

109

Prescriptions dispensed, refills included

Drug cost

$32,033

Paid at the pharmacy, in all

Medicare Part D drugs matched to Clindacin PAC, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Clindacin Clindamycin Phosphate Similar name 3 67 $21,735
Clindacin P Clindamycin Phosphate Similar name 3 42 $10,298

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

5 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Vaughan Graves Dermatology PA 45 $12,796 None on record
Laurence Landau Podiatry NY 22 $8,175 None on record
Denton Mow Physician Assistant NC 16 $3,166 None on record
Corrine Renne Podiatry NY 13 $4,697 None on record
Samantha Landau Podiatry NY 13 $3,199 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

18 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record